nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—CYP19A1—esophageal cancer	0.71	1	CbGaD
Danazol—CCL2—exocrine gland—esophageal cancer	0.00869	0.14	CbGeAlD
Danazol—CCL2—neck—esophageal cancer	0.00555	0.0895	CbGeAlD
Danazol—CCL2—epithelium—esophageal cancer	0.00378	0.0609	CbGeAlD
Danazol—CCL2—bronchus—esophageal cancer	0.00372	0.0599	CbGeAlD
Danazol—CCL2—smooth muscle tissue—esophageal cancer	0.00364	0.0587	CbGeAlD
Danazol—Guillain-Barre syndrome—Methotrexate—esophageal cancer	0.00348	0.0612	CcSEcCtD
Danazol—CCL2—trachea—esophageal cancer	0.00334	0.0538	CbGeAlD
Danazol—SHBG—neck—esophageal cancer	0.00324	0.0522	CbGeAlD
Danazol—CCL2—digestive system—esophageal cancer	0.00288	0.0463	CbGeAlD
Danazol—CCL2—lung—esophageal cancer	0.0024	0.0387	CbGeAlD
Danazol—ESR1—neck—esophageal cancer	0.00228	0.0368	CbGeAlD
Danazol—Pigmentation disorder—Capecitabine—esophageal cancer	0.00203	0.0357	CcSEcCtD
Danazol—PGR—epithelium—esophageal cancer	0.00199	0.032	CbGeAlD
Danazol—PGR—smooth muscle tissue—esophageal cancer	0.00191	0.0308	CbGeAlD
Danazol—Arterial thrombosis—Methotrexate—esophageal cancer	0.00188	0.033	CcSEcCtD
Danazol—Nodule—Methotrexate—esophageal cancer	0.00172	0.0302	CcSEcCtD
Danazol—CCL2—lymph node—esophageal cancer	0.00164	0.0265	CbGeAlD
Danazol—AR—epithelium—esophageal cancer	0.00158	0.0255	CbGeAlD
Danazol—AR—bronchus—esophageal cancer	0.00156	0.0251	CbGeAlD
Danazol—ESR1—epithelium—esophageal cancer	0.00155	0.025	CbGeAlD
Danazol—Hoarseness—Capecitabine—esophageal cancer	0.00154	0.0271	CcSEcCtD
Danazol—AR—smooth muscle tissue—esophageal cancer	0.00152	0.0246	CbGeAlD
Danazol—ESR1—smooth muscle tissue—esophageal cancer	0.0015	0.0241	CbGeAlD
Danazol—Joint swelling—Capecitabine—esophageal cancer	0.00138	0.0243	CcSEcCtD
Danazol—PGR—lung—esophageal cancer	0.00126	0.0203	CbGeAlD
Danazol—AR—digestive system—esophageal cancer	0.0012	0.0194	CbGeAlD
Danazol—ESR1—digestive system—esophageal cancer	0.00118	0.019	CbGeAlD
Danazol—Hirsutism—Capecitabine—esophageal cancer	0.00117	0.0205	CcSEcCtD
Danazol—Ethinyl Estradiol—NR1I2—esophageal cancer	0.00109	0.163	CrCbGaD
Danazol—Hydrocortisone—ANXA1—esophageal cancer	0.00108	0.161	CrCbGaD
Danazol—Interstitial pneumonia—Methotrexate—esophageal cancer	0.00105	0.0184	CcSEcCtD
Danazol—Testolactone—CYP19A1—esophageal cancer	0.00103	0.154	CrCbGaD
Danazol—AR—lung—esophageal cancer	0.00101	0.0162	CbGeAlD
Danazol—ESR1—lung—esophageal cancer	0.000987	0.0159	CbGeAlD
Danazol—Thrombosis—Capecitabine—esophageal cancer	0.000959	0.0168	CcSEcCtD
Danazol—Throat sore—Capecitabine—esophageal cancer	0.000942	0.0165	CcSEcCtD
Danazol—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.000933	0.0164	CcSEcCtD
Danazol—Body temperature increased—Carboplatin—esophageal cancer	0.000886	0.0156	CcSEcCtD
Danazol—Fluid retention—Cisplatin—esophageal cancer	0.000874	0.0154	CcSEcCtD
Danazol—PGR—lymph node—esophageal cancer	0.000863	0.0139	CbGeAlD
Danazol—Dysphonia—Capecitabine—esophageal cancer	0.000825	0.0145	CcSEcCtD
Danazol—CYP19A1—lymph node—esophageal cancer	0.000777	0.0125	CbGeAlD
Danazol—Oropharyngeal pain—Capecitabine—esophageal cancer	0.000747	0.0131	CcSEcCtD
Danazol—Nasal congestion—Cisplatin—esophageal cancer	0.000734	0.0129	CcSEcCtD
Danazol—Interstitial lung disease—Methotrexate—esophageal cancer	0.000714	0.0125	CcSEcCtD
Danazol—Cataract—Capecitabine—esophageal cancer	0.000713	0.0125	CcSEcCtD
Danazol—AR—lymph node—esophageal cancer	0.000688	0.0111	CbGeAlD
Danazol—ESR1—lymph node—esophageal cancer	0.000675	0.0109	CbGeAlD
Danazol—CYP3A4—digestive system—esophageal cancer	0.000659	0.0106	CbGeAlD
Danazol—Fluid retention—Capecitabine—esophageal cancer	0.000644	0.0113	CcSEcCtD
Danazol—Irritability—Cisplatin—esophageal cancer	0.000638	0.0112	CcSEcCtD
Danazol—Cramp muscle—Cisplatin—esophageal cancer	0.000602	0.0106	CcSEcCtD
Danazol—Sleep disorder—Capecitabine—esophageal cancer	0.000569	0.01	CcSEcCtD
Danazol—Pancreatitis—Cisplatin—esophageal cancer	0.000566	0.00995	CcSEcCtD
Danazol—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000564	0.0099	CcSEcCtD
Danazol—Photosensitivity—Capecitabine—esophageal cancer	0.000561	0.00986	CcSEcCtD
Danazol—Gastroenteritis—Capecitabine—esophageal cancer	0.000556	0.00977	CcSEcCtD
Danazol—Levonorgestrel—CYP19A1—esophageal cancer	0.000545	0.0814	CrCbGaD
Danazol—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000508	0.00892	CcSEcCtD
Danazol—Myocardial infarction—Cisplatin—esophageal cancer	0.000505	0.00887	CcSEcCtD
Danazol—Ethinyl Estradiol—ABCC2—esophageal cancer	0.000488	0.0729	CrCbGaD
Danazol—Migraine—Capecitabine—esophageal cancer	0.000485	0.00852	CcSEcCtD
Danazol—Irritability—Capecitabine—esophageal cancer	0.00047	0.00826	CcSEcCtD
Danazol—Mood swings—Capecitabine—esophageal cancer	0.000467	0.0082	CcSEcCtD
Danazol—Abdominal pain upper—Capecitabine—esophageal cancer	0.00045	0.00791	CcSEcCtD
Danazol—Visual impairment—Cisplatin—esophageal cancer	0.000446	0.00783	CcSEcCtD
Danazol—Flushing—Cisplatin—esophageal cancer	0.000429	0.00754	CcSEcCtD
Danazol—Methyltestosterone—CYP19A1—esophageal cancer	0.00042	0.0626	CrCbGaD
Danazol—Photosensitivity—Methotrexate—esophageal cancer	0.000418	0.00734	CcSEcCtD
Danazol—Alopecia—Cisplatin—esophageal cancer	0.000409	0.00718	CcSEcCtD
Danazol—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000389	0.00683	CcSEcCtD
Danazol—Weight increased—Capecitabine—esophageal cancer	0.000388	0.00681	CcSEcCtD
Danazol—Visual disturbance—Methotrexate—esophageal cancer	0.000387	0.0068	CcSEcCtD
Danazol—Muscle spasms—Cisplatin—esophageal cancer	0.000387	0.0068	CcSEcCtD
Danazol—Vision blurred—Cisplatin—esophageal cancer	0.000379	0.00666	CcSEcCtD
Danazol—Tremor—Cisplatin—esophageal cancer	0.000377	0.00662	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000376	0.00661	CcSEcCtD
Danazol—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000374	0.00658	CcSEcCtD
Danazol—Myocardial infarction—Capecitabine—esophageal cancer	0.000372	0.00654	CcSEcCtD
Danazol—Jaundice—Capecitabine—esophageal cancer	0.00037	0.0065	CcSEcCtD
Danazol—Haematuria—Capecitabine—esophageal cancer	0.000362	0.00636	CcSEcCtD
Danazol—Leukopenia—Cisplatin—esophageal cancer	0.00036	0.00633	CcSEcCtD
Danazol—Progesterone—CYP1B1—esophageal cancer	0.000351	0.0524	CrCbGaD
Danazol—Irritability—Methotrexate—esophageal cancer	0.00035	0.00615	CcSEcCtD
Danazol—Convulsion—Cisplatin—esophageal cancer	0.000349	0.00613	CcSEcCtD
Danazol—Mood swings—Methotrexate—esophageal cancer	0.000348	0.0061	CcSEcCtD
Danazol—Haemoglobin—Capecitabine—esophageal cancer	0.000343	0.00602	CcSEcCtD
Danazol—Anxiety—Cisplatin—esophageal cancer	0.000342	0.006	CcSEcCtD
Danazol—Haemorrhage—Capecitabine—esophageal cancer	0.000341	0.00599	CcSEcCtD
Danazol—Testosterone—CYP1B1—esophageal cancer	0.000332	0.0495	CrCbGaD
Danazol—Oedema—Cisplatin—esophageal cancer	0.000329	0.00577	CcSEcCtD
Danazol—Visual impairment—Capecitabine—esophageal cancer	0.000329	0.00577	CcSEcCtD
Danazol—Erythema multiforme—Capecitabine—esophageal cancer	0.000322	0.00566	CcSEcCtD
Danazol—Thrombocytopenia—Cisplatin—esophageal cancer	0.000322	0.00565	CcSEcCtD
Danazol—Tachycardia—Cisplatin—esophageal cancer	0.000321	0.00563	CcSEcCtD
Danazol—Hyperhidrosis—Cisplatin—esophageal cancer	0.000318	0.00558	CcSEcCtD
Danazol—Flushing—Capecitabine—esophageal cancer	0.000316	0.00556	CcSEcCtD
Danazol—Eosinophilia—Methotrexate—esophageal cancer	0.000314	0.00551	CcSEcCtD
Danazol—Pancreatitis—Methotrexate—esophageal cancer	0.000311	0.00546	CcSEcCtD
Danazol—Chills—Capecitabine—esophageal cancer	0.000306	0.00537	CcSEcCtD
Danazol—Alopecia—Capecitabine—esophageal cancer	0.000301	0.00529	CcSEcCtD
Danazol—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000299	0.00526	CcSEcCtD
Danazol—Paraesthesia—Cisplatin—esophageal cancer	0.000295	0.00518	CcSEcCtD
Danazol—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000289	0.00508	CcSEcCtD
Danazol—Back pain—Capecitabine—esophageal cancer	0.000287	0.00504	CcSEcCtD
Danazol—Muscle spasms—Capecitabine—esophageal cancer	0.000285	0.00501	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00028	0.00492	CcSEcCtD
Danazol—Vision blurred—Capecitabine—esophageal cancer	0.00028	0.00491	CcSEcCtD
Danazol—Tremor—Capecitabine—esophageal cancer	0.000278	0.00488	CcSEcCtD
Danazol—Sweating—Methotrexate—esophageal cancer	0.000271	0.00476	CcSEcCtD
Danazol—Progesterone—CYP2A6—esophageal cancer	0.00027	0.0404	CrCbGaD
Danazol—Haematuria—Methotrexate—esophageal cancer	0.00027	0.00473	CcSEcCtD
Danazol—Vertigo—Capecitabine—esophageal cancer	0.000267	0.00468	CcSEcCtD
Danazol—Syncope—Capecitabine—esophageal cancer	0.000266	0.00467	CcSEcCtD
Danazol—Leukopenia—Capecitabine—esophageal cancer	0.000266	0.00467	CcSEcCtD
Danazol—Palpitations—Capecitabine—esophageal cancer	0.000262	0.00461	CcSEcCtD
Danazol—Loss of consciousness—Capecitabine—esophageal cancer	0.000261	0.00458	CcSEcCtD
Danazol—Body temperature increased—Cisplatin—esophageal cancer	0.00026	0.00456	CcSEcCtD
Danazol—Hypertension—Capecitabine—esophageal cancer	0.000256	0.0045	CcSEcCtD
Danazol—Haemoglobin—Methotrexate—esophageal cancer	0.000255	0.00448	CcSEcCtD
Danazol—Haemorrhage—Methotrexate—esophageal cancer	0.000254	0.00446	CcSEcCtD
Danazol—Arthralgia—Capecitabine—esophageal cancer	0.000253	0.00444	CcSEcCtD
Danazol—Anxiety—Capecitabine—esophageal cancer	0.000252	0.00442	CcSEcCtD
Danazol—Visual impairment—Methotrexate—esophageal cancer	0.000245	0.0043	CcSEcCtD
Danazol—Testosterone—CYP19A1—esophageal cancer	0.000243	0.0363	CrCbGaD
Danazol—Oedema—Capecitabine—esophageal cancer	0.000242	0.00425	CcSEcCtD
Danazol—Erythema multiforme—Methotrexate—esophageal cancer	0.00024	0.00421	CcSEcCtD
Danazol—Shock—Capecitabine—esophageal cancer	0.000238	0.00419	CcSEcCtD
Danazol—Thrombocytopenia—Capecitabine—esophageal cancer	0.000237	0.00417	CcSEcCtD
Danazol—Tachycardia—Capecitabine—esophageal cancer	0.000236	0.00415	CcSEcCtD
Danazol—Asthenia—Cisplatin—esophageal cancer	0.000236	0.00414	CcSEcCtD
Danazol—Hyperhidrosis—Capecitabine—esophageal cancer	0.000234	0.00411	CcSEcCtD
Danazol—Chills—Methotrexate—esophageal cancer	0.000228	0.004	CcSEcCtD
Danazol—Alopecia—Methotrexate—esophageal cancer	0.000224	0.00394	CcSEcCtD
Danazol—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000221	0.00388	CcSEcCtD
Danazol—Paraesthesia—Capecitabine—esophageal cancer	0.000217	0.00382	CcSEcCtD
Danazol—Back pain—Methotrexate—esophageal cancer	0.000214	0.00375	CcSEcCtD
Danazol—Dyspepsia—Capecitabine—esophageal cancer	0.000213	0.00374	CcSEcCtD
Danazol—Vomiting—Cisplatin—esophageal cancer	0.000209	0.00367	CcSEcCtD
Danazol—Fatigue—Capecitabine—esophageal cancer	0.000209	0.00367	CcSEcCtD
Danazol—Vision blurred—Methotrexate—esophageal cancer	0.000208	0.00366	CcSEcCtD
Danazol—Rash—Cisplatin—esophageal cancer	0.000207	0.00364	CcSEcCtD
Danazol—Constipation—Capecitabine—esophageal cancer	0.000207	0.00364	CcSEcCtD
Danazol—Dermatitis—Cisplatin—esophageal cancer	0.000207	0.00364	CcSEcCtD
Danazol—Vertigo—Methotrexate—esophageal cancer	0.000198	0.00349	CcSEcCtD
Danazol—Leukopenia—Methotrexate—esophageal cancer	0.000198	0.00347	CcSEcCtD
Danazol—Nausea—Cisplatin—esophageal cancer	0.000195	0.00343	CcSEcCtD
Danazol—Urticaria—Capecitabine—esophageal cancer	0.000192	0.00338	CcSEcCtD
Danazol—Body temperature increased—Capecitabine—esophageal cancer	0.000191	0.00336	CcSEcCtD
Danazol—Convulsion—Methotrexate—esophageal cancer	0.000191	0.00336	CcSEcCtD
Danazol—Arthralgia—Methotrexate—esophageal cancer	0.000188	0.0033	CcSEcCtD
Danazol—Ethinyl Estradiol—ABCB1—esophageal cancer	0.00018	0.0268	CrCbGaD
Danazol—Thrombocytopenia—Methotrexate—esophageal cancer	0.000177	0.0031	CcSEcCtD
Danazol—Prednisone—ABCB1—esophageal cancer	0.000175	0.0262	CrCbGaD
Danazol—Hyperhidrosis—Methotrexate—esophageal cancer	0.000174	0.00306	CcSEcCtD
Danazol—Asthenia—Capecitabine—esophageal cancer	0.000174	0.00305	CcSEcCtD
Danazol—Norethindrone—ABCB1—esophageal cancer	0.000173	0.0258	CrCbGaD
Danazol—Pruritus—Capecitabine—esophageal cancer	0.000171	0.00301	CcSEcCtD
Danazol—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000164	0.00289	CcSEcCtD
Danazol—Paraesthesia—Methotrexate—esophageal cancer	0.000162	0.00284	CcSEcCtD
Danazol—Dizziness—Capecitabine—esophageal cancer	0.00016	0.00281	CcSEcCtD
Danazol—Dyspepsia—Methotrexate—esophageal cancer	0.000159	0.00279	CcSEcCtD
Danazol—Fatigue—Methotrexate—esophageal cancer	0.000155	0.00273	CcSEcCtD
Danazol—Vomiting—Capecitabine—esophageal cancer	0.000154	0.0027	CcSEcCtD
Danazol—Rash—Capecitabine—esophageal cancer	0.000153	0.00268	CcSEcCtD
Danazol—Dermatitis—Capecitabine—esophageal cancer	0.000153	0.00268	CcSEcCtD
Danazol—Headache—Capecitabine—esophageal cancer	0.000152	0.00267	CcSEcCtD
Danazol—Nausea—Capecitabine—esophageal cancer	0.000144	0.00253	CcSEcCtD
Danazol—Urticaria—Methotrexate—esophageal cancer	0.000143	0.00252	CcSEcCtD
Danazol—Body temperature increased—Methotrexate—esophageal cancer	0.000143	0.0025	CcSEcCtD
Danazol—Asthenia—Methotrexate—esophageal cancer	0.000129	0.00227	CcSEcCtD
Danazol—Pruritus—Methotrexate—esophageal cancer	0.000128	0.00224	CcSEcCtD
Danazol—Hydrocortisone—ABCB1—esophageal cancer	0.000124	0.0184	CrCbGaD
Danazol—Dizziness—Methotrexate—esophageal cancer	0.000119	0.00209	CcSEcCtD
Danazol—Vomiting—Methotrexate—esophageal cancer	0.000115	0.00201	CcSEcCtD
Danazol—Rash—Methotrexate—esophageal cancer	0.000114	0.002	CcSEcCtD
Danazol—Dermatitis—Methotrexate—esophageal cancer	0.000114	0.00199	CcSEcCtD
Danazol—Headache—Methotrexate—esophageal cancer	0.000113	0.00198	CcSEcCtD
Danazol—Nausea—Methotrexate—esophageal cancer	0.000107	0.00188	CcSEcCtD
Danazol—Progesterone—ABCB1—esophageal cancer	0.000101	0.015	CrCbGaD
Danazol—Testosterone—ABCB1—esophageal cancer	9.52e-05	0.0142	CrCbGaD
Danazol—ESR1—Generic Transcription Pathway—NOTCH2—esophageal cancer	6.89e-05	0.000419	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PSME1—esophageal cancer	6.89e-05	0.000419	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PSME2—esophageal cancer	6.89e-05	0.000419	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	6.88e-05	0.000419	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ANXA1—esophageal cancer	6.85e-05	0.000417	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CA2—esophageal cancer	6.75e-05	0.000411	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	6.71e-05	0.000408	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—CDKN1A—esophageal cancer	6.69e-05	0.000407	CbGpPWpGaD
Danazol—PGR—Gene Expression—PSME2—esophageal cancer	6.68e-05	0.000406	CbGpPWpGaD
Danazol—PGR—Gene Expression—PSME1—esophageal cancer	6.68e-05	0.000406	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SST—esophageal cancer	6.67e-05	0.000406	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	6.61e-05	0.000402	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	6.6e-05	0.000401	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—CREBBP—esophageal cancer	6.59e-05	0.000401	CbGpPWpGaD
Danazol—AR—Gene Expression—HIST1H2BM—esophageal cancer	6.56e-05	0.000399	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	6.52e-05	0.000397	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NOTCH3—esophageal cancer	6.5e-05	0.000395	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—GHRL—esophageal cancer	6.5e-05	0.000395	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—EP300—esophageal cancer	6.4e-05	0.000389	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—FBXW7—esophageal cancer	6.39e-05	0.000389	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	6.37e-05	0.000388	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NOTCH2—esophageal cancer	6.37e-05	0.000388	CbGpPWpGaD
Danazol—PGR—Gene Expression—NOTCH3—esophageal cancer	6.3e-05	0.000383	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	6.29e-05	0.000383	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PLCE1—esophageal cancer	6.27e-05	0.000382	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ADH7—esophageal cancer	6.27e-05	0.000382	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—MYC—esophageal cancer	6.23e-05	0.000379	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	6.22e-05	0.000378	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ELMO1—esophageal cancer	6.21e-05	0.000378	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KMT2D—esophageal cancer	6.2e-05	0.000377	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	6.09e-05	0.000371	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKAP13—esophageal cancer	6.06e-05	0.000369	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	6e-05	0.000365	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—TP53—esophageal cancer	5.94e-05	0.000362	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	5.9e-05	0.000359	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NR1I2—esophageal cancer	5.89e-05	0.000358	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	5.87e-05	0.000357	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NOTCH2—esophageal cancer	5.83e-05	0.000354	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—SMAD4—esophageal cancer	5.78e-05	0.000352	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	5.76e-05	0.00035	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TGFBR2—esophageal cancer	5.65e-05	0.000344	CbGpPWpGaD
Danazol—PGR—Gene Expression—NOTCH2—esophageal cancer	5.65e-05	0.000344	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HIST1H2BM—esophageal cancer	5.6e-05	0.000341	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—MYC—esophageal cancer	5.57e-05	0.000339	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	5.57e-05	0.000339	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PDE4D—esophageal cancer	5.55e-05	0.000337	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—NOTCH1—esophageal cancer	5.54e-05	0.000337	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADCYAP1—esophageal cancer	5.52e-05	0.000336	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ADH1B—esophageal cancer	5.5e-05	0.000335	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	5.45e-05	0.000332	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—EGFR—esophageal cancer	5.42e-05	0.00033	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SMAD4—esophageal cancer	5.35e-05	0.000325	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	5.3e-05	0.000323	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GNG7—esophageal cancer	5.28e-05	0.000321	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TYMP—esophageal cancer	5.26e-05	0.00032	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TGFBR2—esophageal cancer	5.17e-05	0.000314	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP26A1—esophageal cancer	5.11e-05	0.000311	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TP53—esophageal cancer	5.11e-05	0.000311	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	5.09e-05	0.00031	CbGpPWpGaD
Danazol—AR—Gene Expression—PSME2—esophageal cancer	5.09e-05	0.00031	CbGpPWpGaD
Danazol—AR—Gene Expression—PSME1—esophageal cancer	5.09e-05	0.00031	CbGpPWpGaD
Danazol—ESR1—Gene Expression—HIST1H2BM—esophageal cancer	5.05e-05	0.000307	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—WWOX—esophageal cancer	5.05e-05	0.000307	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—CREBBP—esophageal cancer	5.02e-05	0.000305	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	5.01e-05	0.000305	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ALOX15—esophageal cancer	4.98e-05	0.000303	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	4.94e-05	0.000301	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—XIAP—esophageal cancer	4.94e-05	0.000301	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	4.92e-05	0.0003	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SMAD4—esophageal cancer	4.89e-05	0.000298	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FKBP1A—esophageal cancer	4.81e-05	0.000292	CbGpPWpGaD
Danazol—AR—Gene Expression—NOTCH3—esophageal cancer	4.8e-05	0.000292	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTO1—esophageal cancer	4.76e-05	0.000289	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TPI1—esophageal cancer	4.76e-05	0.000289	CbGpPWpGaD
Danazol—PGR—Gene Expression—SMAD4—esophageal cancer	4.75e-05	0.000289	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	4.71e-05	0.000287	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—PIK3CA—esophageal cancer	4.71e-05	0.000286	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—WIF1—esophageal cancer	4.7e-05	0.000286	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CTNNA1—esophageal cancer	4.68e-05	0.000284	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	4.65e-05	0.000283	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCL2—esophageal cancer	4.65e-05	0.000283	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	4.62e-05	0.000281	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—TP53—esophageal cancer	4.58e-05	0.000279	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ALDOB—esophageal cancer	4.56e-05	0.000277	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	4.52e-05	0.000275	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GAPDH—esophageal cancer	4.39e-05	0.000267	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HIF1A—esophageal cancer	4.38e-05	0.000266	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CRABP1—esophageal cancer	4.35e-05	0.000265	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PSME2—esophageal cancer	4.34e-05	0.000264	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PSME1—esophageal cancer	4.34e-05	0.000264	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CSNK1A1—esophageal cancer	4.33e-05	0.000264	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ANXA1—esophageal cancer	4.32e-05	0.000263	CbGpPWpGaD
Danazol—AR—Gene Expression—NOTCH2—esophageal cancer	4.31e-05	0.000262	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—NOTCH1—esophageal cancer	4.26e-05	0.000259	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SST—esophageal cancer	4.2e-05	0.000256	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KDR—esophageal cancer	4.19e-05	0.000255	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GNG7—esophageal cancer	4.14e-05	0.000252	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOTCH3—esophageal cancer	4.1e-05	0.000249	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GHRL—esophageal cancer	4.1e-05	0.000249	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PFN1—esophageal cancer	4.05e-05	0.000247	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FBXW7—esophageal cancer	4.03e-05	0.000245	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HIF1A—esophageal cancer	4e-05	0.000244	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NOTCH1—esophageal cancer	3.94e-05	0.00024	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.92e-05	0.000239	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PSME2—esophageal cancer	3.92e-05	0.000238	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PSME1—esophageal cancer	3.92e-05	0.000238	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—MYC—esophageal cancer	3.91e-05	0.000238	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ALDH2—esophageal cancer	3.88e-05	0.000236	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—CREBBP—esophageal cancer	3.87e-05	0.000235	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KDR—esophageal cancer	3.83e-05	0.000233	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.79e-05	0.000231	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NOTCH3—esophageal cancer	3.7e-05	0.000225	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTT1—esophageal cancer	3.69e-05	0.000224	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOTCH2—esophageal cancer	3.67e-05	0.000224	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP2A6—esophageal cancer	3.64e-05	0.000222	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ELMO1—esophageal cancer	3.64e-05	0.000222	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.63e-05	0.000221	CbGpPWpGaD
Danazol—AR—Gene Expression—SMAD4—esophageal cancer	3.62e-05	0.00022	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NOTCH1—esophageal cancer	3.61e-05	0.000219	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CREBBP—esophageal cancer	3.58e-05	0.000218	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKAP13—esophageal cancer	3.56e-05	0.000217	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—EGFR—esophageal cancer	3.51e-05	0.000214	CbGpPWpGaD
Danazol—PGR—Gene Expression—NOTCH1—esophageal cancer	3.5e-05	0.000213	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ENO1—esophageal cancer	3.45e-05	0.00021	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS1—esophageal cancer	3.45e-05	0.00021	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PSME1—esophageal cancer	3.4e-05	0.000207	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PSME2—esophageal cancer	3.4e-05	0.000207	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NOTCH2—esophageal cancer	3.32e-05	0.000202	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HIST1H2BM—esophageal cancer	3.28e-05	0.0002	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CREBBP—esophageal cancer	3.27e-05	0.000199	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TGFBR2—esophageal cancer	3.26e-05	0.000198	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PDE4D—esophageal cancer	3.26e-05	0.000198	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—EGFR—esophageal cancer	3.21e-05	0.000195	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NOS3—esophageal cancer	3.2e-05	0.000195	CbGpPWpGaD
Danazol—PGR—Gene Expression—CREBBP—esophageal cancer	3.17e-05	0.000193	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GNG7—esophageal cancer	3.1e-05	0.000188	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SMAD4—esophageal cancer	3.09e-05	0.000188	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—PIK3CA—esophageal cancer	3.07e-05	0.000187	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—PIK3CA—esophageal cancer	3.05e-05	0.000186	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ERBB2—esophageal cancer	2.99e-05	0.000182	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—MYC—esophageal cancer	2.98e-05	0.000181	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.97e-05	0.000181	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP1B1—esophageal cancer	2.94e-05	0.000179	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NOS3—esophageal cancer	2.93e-05	0.000178	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—XIAP—esophageal cancer	2.9e-05	0.000177	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—PIK3CA—esophageal cancer	2.79e-05	0.00017	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SMAD4—esophageal cancer	2.79e-05	0.000169	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CTNNA1—esophageal cancer	2.74e-05	0.000167	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ERBB2—esophageal cancer	2.74e-05	0.000167	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL2—esophageal cancer	2.73e-05	0.000166	CbGpPWpGaD
Danazol—AR—Gene Expression—NOTCH1—esophageal cancer	2.67e-05	0.000162	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCND1—esophageal cancer	2.65e-05	0.000161	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CDKN1A—esophageal cancer	2.56e-05	0.000156	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PSME2—esophageal cancer	2.55e-05	0.000155	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PSME1—esophageal cancer	2.55e-05	0.000155	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ANXA1—esophageal cancer	2.54e-05	0.000154	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.53e-05	0.000154	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.53e-05	0.000154	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HIF1A—esophageal cancer	2.52e-05	0.000154	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—HMOX1—esophageal cancer	2.52e-05	0.000153	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.47e-05	0.00015	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SST—esophageal cancer	2.47e-05	0.00015	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EP300—esophageal cancer	2.44e-05	0.000148	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCND1—esophageal cancer	2.42e-05	0.000147	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ABCB1—esophageal cancer	2.42e-05	0.000147	CbGpPWpGaD
Danazol—AR—Gene Expression—CREBBP—esophageal cancer	2.42e-05	0.000147	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KDR—esophageal cancer	2.41e-05	0.000147	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOTCH3—esophageal cancer	2.4e-05	0.000146	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GHRL—esophageal cancer	2.4e-05	0.000146	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FBXW7—esophageal cancer	2.37e-05	0.000144	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CDKN1A—esophageal cancer	2.34e-05	0.000142	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MYC—esophageal cancer	2.29e-05	0.00014	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOTCH1—esophageal cancer	2.27e-05	0.000138	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EP300—esophageal cancer	2.23e-05	0.000135	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOTCH2—esophageal cancer	2.16e-05	0.000131	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.15e-05	0.000131	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CA1—esophageal cancer	2.15e-05	0.000131	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MYC—esophageal cancer	2.12e-05	0.000129	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EGFR—esophageal cancer	2.08e-05	0.000126	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CREBBP—esophageal cancer	2.06e-05	0.000125	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NOTCH1—esophageal cancer	2.05e-05	0.000125	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CA2—esophageal cancer	1.97e-05	0.00012	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MYC—esophageal cancer	1.94e-05	0.000118	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFBR2—esophageal cancer	1.91e-05	0.000116	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EGFR—esophageal cancer	1.9e-05	0.000115	CbGpPWpGaD
Danazol—PGR—Gene Expression—MYC—esophageal cancer	1.88e-05	0.000115	CbGpPWpGaD
Danazol—ESR1—Gene Expression—CREBBP—esophageal cancer	1.86e-05	0.000113	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOS3—esophageal cancer	1.85e-05	0.000112	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ADH7—esophageal cancer	1.83e-05	0.000111	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.83e-05	0.000111	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.83e-05	0.000111	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SMAD4—esophageal cancer	1.81e-05	0.00011	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CA—esophageal cancer	1.8e-05	0.00011	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—esophageal cancer	1.74e-05	0.000106	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ERBB2—esophageal cancer	1.73e-05	0.000105	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CA—esophageal cancer	1.65e-05	0.0001	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CREBBP—esophageal cancer	1.62e-05	9.84e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.61e-05	9.77e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—esophageal cancer	1.59e-05	9.7e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TYMP—esophageal cancer	1.53e-05	9.34e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCND1—esophageal cancer	1.53e-05	9.28e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.49e-05	9.08e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HIF1A—esophageal cancer	1.48e-05	9.01e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDKN1A—esophageal cancer	1.48e-05	8.98e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.45e-05	8.85e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NOS3—esophageal cancer	1.45e-05	8.81e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—MYC—esophageal cancer	1.43e-05	8.72e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KDR—esophageal cancer	1.42e-05	8.62e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EP300—esophageal cancer	1.4e-05	8.54e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.39e-05	8.44e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TPI1—esophageal cancer	1.39e-05	8.44e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOTCH1—esophageal cancer	1.33e-05	8.12e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.33e-05	8.09e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—esophageal cancer	1.32e-05	8.05e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.28e-05	7.79e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.27e-05	7.72e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MYC—esophageal cancer	1.22e-05	7.45e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CREBBP—esophageal cancer	1.21e-05	7.36e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GNG7—esophageal cancer	1.21e-05	7.34e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EGFR—esophageal cancer	1.2e-05	7.28e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.13e-05	6.88e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MYC—esophageal cancer	1.1e-05	6.72e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—EP300—esophageal cancer	1.1e-05	6.7e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOS3—esophageal cancer	1.08e-05	6.59e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.08e-05	6.55e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.06e-05	6.47e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CA—esophageal cancer	1.04e-05	6.32e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ERBB2—esophageal cancer	1.01e-05	6.17e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.01e-05	6.13e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ENO1—esophageal cancer	1.01e-05	6.13e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—esophageal cancer	1.01e-05	6.11e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PSME2—esophageal cancer	9.93e-06	6.04e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PSME1—esophageal cancer	9.93e-06	6.04e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCND1—esophageal cancer	8.95e-06	5.45e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN1A—esophageal cancer	8.66e-06	5.27e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP1B1—esophageal cancer	8.57e-06	5.22e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EP300—esophageal cancer	8.24e-06	5.01e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CA—esophageal cancer	8.15e-06	4.96e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP19A1—esophageal cancer	8.06e-06	4.9e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HMOX1—esophageal cancer	7.36e-06	4.47e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MYC—esophageal cancer	7.18e-06	4.37e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCB1—esophageal cancer	7.06e-06	4.3e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EGFR—esophageal cancer	7.03e-06	4.27e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CA—esophageal cancer	6.1e-06	3.71e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—esophageal cancer	5.9e-06	3.59e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CREBBP—esophageal cancer	4.72e-06	2.87e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NOS3—esophageal cancer	4.22e-06	2.57e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.86e-06	2.35e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—EP300—esophageal cancer	3.21e-06	1.96e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.38e-06	1.45e-05	CbGpPWpGaD
